Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : mRNA-Based Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : MOPCTx platform, comprised of a modified mRNA encapsulated in a lipid nanoparticle, can code for a viral or bacterial antigen or a molecular adjuvant. Platform produced vaccine had shown strong immunogenicity and protection in hamsters from COVID-19 chal...
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
March 30, 2023
Lead Product(s) : mRNA-Based Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
